Cargando…
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM
BACKGROUND: There is no data regarding COVID-19 in Multiple Sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients in Latin America. OBJECTIVE: The objective of this study was to describe the clinical characteristics and outcomes of patients included in RELACOEM, a LATAM registry...
Ejemplares similares
-
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
por: Carnero Contentti, Edgar, et al.
Publicado: (2023) -
Assessing attacks and treatment response rates among adult patients
with NMOSD and MOGAD: Data from a nationwide registry in
Argentina
por: Contentti, Edgar Carnero, et al.
Publicado: (2021) -
Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
por: Ysrraelit, Maria Celica, et al.
Publicado: (2021) -
Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis
por: Alonso, Ricardo, et al.
Publicado: (2022) -
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM
por: Rojas, Juan I., et al.
Publicado: (2022)